New fascaplysin-based CDK4-specific inhibitors: design, synthesis and biological activity.

De Montfort University Open Research Archive

Show simple item record

dc.contributor.author Chaudhuri, B.
dc.contributor.author Aubry, C.
dc.contributor.author Jenkins, Paul R.
dc.contributor.author Mahale, S.
dc.contributor.author Maréchal, Jean-Didier
dc.contributor.author Sutcliffe, Michael J.
dc.date.accessioned 2009-03-18T16:35:53Z
dc.date.available 2009-03-18T16:35:53Z
dc.date.issued 2004-06-25
dc.identifier.citation Aubry, C. et al (2004) New fascaplysin-based CDK4-specific inhibitors: design, synthesis and biological activity. Chemical Communications, 15, pp. 1696-1697. en
dc.identifier.issn 1364-548X
dc.identifier.uri http://hdl.handle.net/2086/1335
dc.language.iso en en
dc.publisher Royal Society of Chemistry en
dc.subject RAE 2008 en
dc.subject UoA 13 Pharmacy en
dc.title New fascaplysin-based CDK4-specific inhibitors: design, synthesis and biological activity. en
dc.type Article en
dc.identifier.doi http://dx.doi.org/10.1039/b406076h
dc.researchgroup Chemistry for Health


Files in this item

This item appears in the following Collection(s)

Show simple item record